The Board has determined that the Veteran's keratosis does not meet the criteria for a compensable rating, as his condition does not involve at least 5% of the entire body or exposed areas affected, and no systemic therapy is required.
The deciding factor: The evidence did not show characteristic lesions involving more than 20% of the entire body or exposed areas affected, nor did it demonstrate intermittent systemic therapy including corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of less than 6 weeks over the past 12-month period.
- Claimed conditions
- Benign Skin Lesions, Keratosis, Squamous Cell Carcinoma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- July 8, 2024
- Citation
- A24036164
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A24036164.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board has denied a compensable evaluation for bilateral hearing loss and remanded the claim of entitlement to a compensable rating for residuals of squamous cell carcinoma due to inadequate examination.
- Whole decision: Granted
The Board has restored service connection for Ischemic Heart Disease, Squamous Cell Carcinoma, Diabetes Mellitus type II, Chronic Kidney Disease, Diabetic Peripheral Neuropathy of the lower left extremity sciatic nerve, Diabetic Peripheral Neuropathy of the lower right extremity sciatic nerve, and Hypertension. The Board found that the original grant of service connection was not clearly erroneous due to the Veteran's exposure along the DMZ in Korea.
- Whole decision: Remanded (sent back)
The Veteran's non-VA care on June 6, 2019 for a Squamous Cell Carcinoma was denied because it was not deemed emergent and prior authorization was required. The Board finds the decision insufficient to determine if the care was emergent and remands for proper notice under 38 U.S.C. § 5104.
- Whole decision: Granted
The Veteran's service-connected seborrhea with actinic keratosis and squamous cell carcinoma was found to affect more than 40 percent of his entire body, warranting a 60% disability rating.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.